Drug & intervention
sonrotoclax 80 MG Oral Tablet [Beqalzi]
RxCUI 2750270
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
BeqalziBN · CureCurrent ID 81920
sonrotoclax 1 MG [Beqalzi]SBDC · CureCurrent ID 81921
sonrotoclax 5 MG [Beqalzi]SBDC · CureCurrent ID 81926
sonrotoclax 20 MG [Beqalzi]SBDC · CureCurrent ID 81930
sonrotoclax 80 MG [Beqalzi]SBDC · CureCurrent ID 81934
sonrotoclax Oral Tablet [Beqalzi]SBDF · CureCurrent ID 81922
sonrotoclax 1 MG Oral Tablet [Beqalzi]SBD · CureCurrent ID 81923
sonrotoclax 5 MG Oral Tablet [Beqalzi]SBD · CureCurrent ID 81927
sonrotoclax 20 MG Oral Tablet [Beqalzi]SBD · CureCurrent ID 81931
{11 (sonrotoclax 1 MG Oral Tablet [Beqalzi]) / 11 (sonrotoclax 20 MG Oral Tablet [Beqalzi]) / 11 (sonrotoclax 5 MG Oral Tablet [Beqalzi]) / 11 (sonrotoclax 80 MG Oral Tablet [Beqalzi]) } Pack [Beqalzi Starter Pack]BPCK · CureCurrent ID 81937
Molecular structure
Active ingredient: sonrotoclaxAdvertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.